Showing results (171-180 of 185) with videos related to
Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology|August 29, 2024
Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitisSinéad Ryan, Louise Crowe, Sofía N Almeida Cruz, et al.Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.Neuro-Oncology|July 24, 2023
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progressionArthur R Wolin, Melanie Y Vincent, Taylor Hotz, et al.Elife|December 31, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.Cell Reports|November 14, 2019
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down SyndromeKatherine A Waugh, Paula Araya, Ahwan Pandey, et al.Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.Cancer Research|April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and MetastasisHengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.The New Phytologist|June 18, 2010
Shifts in plant respiration and carbon use efficiency at a large-scale drought experiment in the eastern AmazonD B Metcalfe, P Meir, L E O C Aragão, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.Pageof 19